Literature DB >> 19774375

The long-term clinical and MRI results following eccentric calf muscle training in chronic Achilles tendinosis.

Anna Gärdin1, Tomas Movin, Leif Svensson, Adel Shalabi.   

Abstract

PURPOSE: To evaluate the long-term results following eccentric calf-muscle training in patients with chronic Achilles tendinopathy.
MATERIALS AND METHODS: A total of 24 patients with chronic Achilles tendinopathy were included in a study evaluating MRI findings and clinical symptoms before and after 3 months of daily eccentric calf-muscle strength training. Median duration of symptoms was 18 months (range 6-120). Four of the patients did not perform the prescribed treatment for different reasons and were followed for 14 months. The resulting 20 treated patients completed 4.2-year (range 29-58 months) follow up. Tendon volume was evaluated by using 3D seed growing technique and signal abnormalities were visually semi-quantitatively graded. Level of pain and performance was categorized using a questionnaire completed by the patient.
RESULTS: In the symptomatic treated patients, median intensity level of pain decreased from moderate/severe at time of inclusion to mild at follow up (p < 0.05). Median level of performance increased from severe impairment at time of inclusion to normal at follow up (p < 0.05). 12 out of 20 patients had raised intratendinous signal at time of inclusion compared to 2 out of 20 patients at follow up (p < 0.001). Mean tendon-volume measured 6.7 cm(3) (SD 2.0) at time of inclusion and 6.4 cm(3) (SD 2.0) at follow up (p = 0.18). The four symptomatic non-treated tendons did not improve regarding pain, performance, intratendinous signal or tendon volume.
CONCLUSION: We found decreased pain, improved performance and decreased intratendinous signal both compared to index examination and immediately after the 3 months training regimen in a 4.2-year clinical and MRI follow up, in a group of patients treated with heavy loaded eccentric calf-muscle training for chronic Achilles tendinopathy. The improvements were greater at 4.2-year follow up, despite no further active treatment, than immediately after the treatment. This may indicate a good long-term prognosis for Achilles tendinosis patients.

Entities:  

Mesh:

Year:  2009        PMID: 19774375     DOI: 10.1007/s00256-009-0798-3

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  33 in total

1.  Tendon pathology in long-standing achillodynia. Biopsy findings in 40 patients.

Authors:  T Movin; A Gad; F P Reinholt; C Rolf
Journal:  Acta Orthop Scand       Date:  1997-04

Review 2.  Interventions for treating acute and chronic Achilles tendinitis.

Authors:  G J McLauchlan; H H Handoll
Journal:  Cochrane Database Syst Rev       Date:  2001

3.  Reliability in the assessment of tendon volume and intratendinous signal of the Achilles tendon on MRI: a methodological description.

Authors:  Adel Shalabi; Tomas Movin; Maria Kristoffersen-Wiberg; Peter Aspelin; Leif Svensson
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2004-11-26       Impact factor: 4.342

4.  Vascular NK-1 receptor occurrence in normal and chronic painful Achilles and patellar tendons: studies on chemically unfixed as well as fixed specimens.

Authors:  Sture Forsgren; Patrik Danielson; Håkan Alfredson
Journal:  Regul Pept       Date:  2005-03-30

5.  Magnetic resonance signal, rather than tendon volume, correlates to pain and functional impairment in chronic Achilles tendinopathy.

Authors:  A Gärdin; J Bruno; T Movin; M Kristoffersen-Wiberg; A Shalabi
Journal:  Acta Radiol       Date:  2006-09       Impact factor: 1.990

6.  Intratendinous glutamate levels and eccentric training in chronic Achilles tendinosis: a prospective study using microdialysis technique.

Authors:  Håkan Alfredson; Ronny Lorentzon
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2003-04-24       Impact factor: 4.342

7.  Eccentric exercise in treatment of Achilles tendinopathy.

Authors:  J Nørregaard; C C Larsen; T Bieler; H Langberg
Journal:  Scand J Med Sci Sports       Date:  2007-04       Impact factor: 4.221

8.  Ultrasound guided sclerosis of neovessels in painful chronic Achilles tendinosis: pilot study of a new treatment.

Authors:  Lars Ohberg; H Alfredson
Journal:  Br J Sports Med       Date:  2002-06       Impact factor: 13.800

9.  Effects on neovascularisation behind the good results with eccentric training in chronic mid-portion Achilles tendinosis?

Authors:  Lars Ohberg; Håkan Alfredson
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2004-04-02       Impact factor: 4.342

10.  Is vasculo-neural ingrowth the cause of pain in chronic Achilles tendinosis? An investigation using ultrasonography and colour Doppler, immunohistochemistry, and diagnostic injections.

Authors:  Håkan Alfredson; Lars Ohberg; Sture Forsgren
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2003-08-09       Impact factor: 4.342

View more
  14 in total

1.  ICON 2020-International Scientific Tendinopathy Symposium Consensus: A Systematic Review of Outcome Measures Reported in Clinical Trials of Achilles Tendinopathy.

Authors:  Karin Grävare Silbernagel; Peter Malliaras; Robert-Jan de Vos; Shawn Hanlon; Mitchel Molenaar; Håkan Alfredson; Inge van den Akker-Scheek; Jarrod Antflick; Mathijs van Ark; Kenneth Färnqvist; Zubair Haleem; Jean-Francois Kaux; Paul Kirwan; Bhavesh Kumar; Trevor Lewis; Adrian Mallows; Lorenzo Masci; Dylan Morrissey; Myles Murphy; Richard Newsham-West; Richard Norris; Seth O'Neill; Koen Peers; Igor Sancho; Kayla Seymore; Patrick Vallance; Arco van der Vlist; Bill Vicenzino
Journal:  Sports Med       Date:  2021-11-19       Impact factor: 11.136

Review 2.  Achilles and patellar tendinopathy loading programmes : a systematic review comparing clinical outcomes and identifying potential mechanisms for effectiveness.

Authors:  Peter Malliaras; Christian J Barton; Neil D Reeves; Henning Langberg
Journal:  Sports Med       Date:  2013-04       Impact factor: 11.136

Review 3.  Conservative management of midportion Achilles tendinopathy: a mixed methods study, integrating systematic review and clinical reasoning.

Authors:  Victoria Rowe; Stephanie Hemmings; Christian Barton; Peter Malliaras; Nicola Maffulli; Dylan Morrissey
Journal:  Sports Med       Date:  2012-11-01       Impact factor: 11.136

4.  WHY ARE ECCENTRIC EXERCISES EFFECTIVE FOR ACHILLES TENDINOPATHY?

Authors:  Seth O'Neill; Paul J Watson; Simon Barry
Journal:  Int J Sports Phys Ther       Date:  2015-08

5.  Pathogenesis and Management of Tendinopathies in Sports Medicine.

Authors:  Matthew P Mead; Jonathan P Gumucio; Tariq M Awan; Christopher L Mendias; Kristoffer B Sugg
Journal:  Transl Sports Med       Date:  2017-12-19

6.  COMPARISON OF FUNCTIONAL ACTIVITIES ON STRUCTURAL CHANGES OF THE INFERIOR PATELLAR POLE.

Authors:  Kelli McKinney; Harvey Wallmann; Patrick Stalcup; Katie DiTommaso
Journal:  Int J Sports Phys Ther       Date:  2017-12

7.  EVALUATING THE PROGRESS OF MID-PORTION ACHILLES TENDINOPATHY DURING REHABILITATION: A REVIEW OF OUTCOME MEASURES FOR MUSCLE STRUCTURE AND FUNCTION, TENDON STRUCTURE, AND NEURAL AND PAIN ASSOCIATED MECHANISMS.

Authors:  Myles Murphy; Ebonie Rio; James Debenham; Sean Docking; Mervyn Travers; William Gibson
Journal:  Int J Sports Phys Ther       Date:  2018-06

8.  EVALUATING THE PROGRESS OF MID-PORTION ACHILLES TENDINOPATHY DURING REHABILITATION: A REVIEW OF OUTCOME MEASURES FOR SELF- REPORTED PAIN AND FUNCTION.

Authors:  Myles Murphy; Ebonie Rio; James Debenham; Sean Docking; Mervyn Travers; William Gibson
Journal:  Int J Sports Phys Ther       Date:  2018-04

9.  Tendinopathy in sport.

Authors:  Paul W Ackermann; Per Renström
Journal:  Sports Health       Date:  2012-05       Impact factor: 3.843

10.  A 5-year follow-up study of Alfredson's heel-drop exercise programme in chronic midportion Achilles tendinopathy.

Authors:  A van der Plas; S de Jonge; R J de Vos; H J L van der Heide; J A N Verhaar; A Weir; J L Tol
Journal:  Br J Sports Med       Date:  2011-11-10       Impact factor: 13.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.